Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity.

Journal:
Proceedings of the National Academy of Sciences of the United States of America
Published:
DOI:
10.1073/pnas.2014441117
Affiliations:
13
Authors:
35
Go to article
Institutions Authors Share
Catholic University of Leuven (KU Leuven), Belgium
22.500000
22.500000
22.500000
 0.64
Biomedical Sciences Group, KU Leuven, Belgium
5.500000
 0.16
UCL, United Kingdom (UK)
3.000000
 0.09
Emerging Viral Diseases (EPV), France
1.000000
 0.03
Ghent University Hospital, Belgium
1.000000
 0.03
Emerging Viral Diseases Unit (UVE), France
1.000000
 0.03
University Hospitals Leuven (UZ Leuven), Belgium
0.500000
 0.01
Global Virus Network (GVN), United States of America (USA)
0.500000
 0.01